Transcriptomics

Dataset Information

0

Radiation Therapy Inhances Immunotherapy Response in  Microsatellite-stable Colorectal and Pancreatic Adenocarcinoma in a Phase II Trial


ABSTRACT: Immune checkpoint blockade has limited efficacy in microsatellite stable (MSS) colorectal (CRC) and pancreatic (PDAC) cancer. Preclinical models have demonstrated the use of radiation to activate the innate immune response and stimulate responsiveness to immune checkpoint blockade. Here, we describe a Phase 2 trial of radiation therapy combined with combined anti-CTLA4 (ipilimumab) and anti-PD1 (nivolumab) antibodies in MSS CRC and PDAC. In the per protocol analysis disease control rate was 37% (10/27) in CRC and 29% (5/17) in PDAC with an overall response rate of 15% (4/27) and 18% (3/17), respectively. Whole exome and RNA sequencing of biopsies from 17 patients revealed low tumor mutational burden in all tumors, but a notable upregulation of interferon stimulated genes with concordant high expression of multiple repeat RNA transcripts in responders. Altogether, this study provides foundational human proof of concept of radiation with combination immune checkpoint blockade therapy in otherwise immunotherapy resistant cancers. 

ORGANISM(S): Homo sapiens

PROVIDER: GSE179351 | GEO | 2021/07/06

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2024-01-01 | GSE202361 | GEO
| 2318393 | ecrin-mdr-crc
2023-11-17 | MODEL2310150001 | BioModels
2023-07-05 | GSE235919 | GEO
2023-07-05 | GSE235917 | GEO
2021-11-29 | E-MTAB-11187 | biostudies-arrayexpress
2021-11-13 | E-MTAB-9954 | biostudies-arrayexpress
2023-12-02 | GSE249124 | GEO
2023-11-26 | GSE248570 | GEO
2024-10-24 | GSE268364 | GEO